Cann Group Ltd (ASX:CAN) chairman Julian Chick talks Proactive through the medicinal cannabis producer’s FY23 highlights. The company enjoyed revenue from sales of $13.78 million - representing a 115% increase on FY22 - while total revenue for the year came in at $21.68 million. He says the improvement was driven by the domestic market, with strong sales momentum supported by new clients entering into supply agreements and several existing clients with repeat orders. Cann’s flagship Mildura facility has now been commercially harvesting for over a year, with the facility’s latest harvested crop area equating to an annualised production level of 8 tonnes – double the size of previous harvests.
Cann Group has clear focus on commercial activity and revenue growth
